Companies

TuHURA Biosciences, Inc./NV (HURA) SEC filings

CIK 0001498382 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in NV · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)00
Net income (USD)-22.7 M-38.3 M
Diluted EPS (USD/shares)-0.63-2.47

Latest filings

FiledFormDescriptionPeriod
2026-10-168-K8-K items 2.03,9.012026-10-09
2026-09-248-K8-K items 2.03,9.012026-09-21
2026-09-178-K8-K items 2.03,9.012026-09-14
2026-09-178-K/A8-K/A items 5.02,9.012026-09-10
2026-09-168-K8-K items 5.02,9.012026-09-10
2026-09-048-K8-K items 2.03,9.012026-09-02
2026-08-28SCHEDULE 13D/ASCHEDULE 13D/A
2026-08-218-K8-K items 2.03,9.012026-08-20
2026-08-198-K8-K items 3.02,5.07,9.012026-08-18
2026-08-1410-Q10-Q2026-06-30
2026-08-148-K8-K items 2.02,9.012026-08-14
2026-08-138-K8-K items 2.03,9.012026-08-07
2026-07-298-K8-K items 2.03,9.012026-07-28
2026-07-09ARSARS2025-12-31
2026-07-09DEFA14ADEFA14A
2026-07-09DEF 14ADEF 14A2026-08-18
2026-07-078-K8-K items 2.03,9.012026-06-30
2026-06-26PRE 14APRE 14A2026-08-18
2026-06-178-K8-K items 5.082026-06-17
2026-05-298-K8-K items 2.03,9.012026-05-26
2026-05-294FORM 42026-05-28
2026-05-1510-Q10-Q2026-03-31
2026-05-158-K8-K items 2.02,7.01,9.012026-05-15
2026-04-308-K/A8-K/A items 8.01,9.012026-04-02
2026-04-3010-K/A10-K/A2025-12-31

Forms on file (last 1,000): 4 274, 8-K 218, 10-Q 47, CORRESP 37, 425 33, 3 26, UPLOAD 24, EFFECT 22. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=HURA (0.002 USD), /gw/filings/filings?ticker=HURA&form=8-K, /gw/filings/facts?ticker=HURA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange